文献速递妇科

微小RNA-138通过反向调控TCF3基因成为人宫颈癌的潜在生物标志物和抑癌因子

MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
PubMed 文献 · Gynecol Oncol · 2017-04-04

研究检测了miR-138在宫颈癌细胞系和人肿瘤中的表达,分析其与临床病理因素及总生存的相关性,并在SiHa和HeLa细胞中上调和下调miR-138以评估其对增殖、侵袭和移植瘤生长的影响,同时验证下游靶基因TCF3。结果显示miR-138在宫颈肿瘤和细胞系中下调,低表达与不良生存相关,上调可抑制增殖和侵袭,TCF3受miR-138调控且在人宫颈癌中上调。

要点

  • miR-138在宫颈肿瘤和宫颈癌细胞系中均下调,低表达与患者临床病理因素及不良生存密切相关。
  • 在SiHa和HeLa细胞中,慢病毒诱导的miR-138上调可抑制体外增殖和侵袭以及体内移植瘤生长。
  • TCF3受miR-138调控且在宫颈肿瘤和细胞系中上调,SiRNA介导的TCF3下调可显著抑制体外增殖和侵袭。

核心结论

  • miR-138可能是宫颈癌的抑癌因子和潜在预后生物标志物,其下游靶标TCF3可能以与miR-138相反的方式调控癌症发展。

研究设计与样本

  • 在宫颈癌细胞系和人肿瘤中通过qRT-PCR检测miR-138表达,分析患者临床病理因素及总生存与miR-138表达的相关性。
  • 在SiHa和HeLa细胞中上调和下调miR-138,评估其对体外增殖、侵袭和体内移植瘤生长的调控。
  • 通过双荧光素酶报告基因实验和qRT-PCR分析miR-138的下游靶基因TCF3在宫颈肿瘤和宫颈癌细胞系中的表达。
  • 在SiHa和HeLa细胞中上调和下调TCF3,进一步评估其在调控宫颈癌增殖和侵袭中的作用。

主要发现

  • miR-138在宫颈肿瘤和宫颈癌细胞系中均下调。
  • 宫颈肿瘤中miR-138低表达与患者临床病理因素和不良生存密切相关。
  • 在SiHa和HeLa细胞中,慢病毒诱导的miR-138上调抑制体外癌症增殖和侵袭以及体内移植瘤生长,而miR-138下调影响不大。
  • TCF3被证实受miR-138调控,且在宫颈癌肿瘤和细胞系中上调。
  • SiRNA介导的TCF3下调显著抑制体外宫颈癌增殖和侵袭,但TCF3过表达对体外宫颈癌增殖和侵袭无影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of our work is to identify the functional mechanism of microRNA-138 (miR-138) in human cervical cancer. METHODS: MiR-138 expression was investigated by qRT-PCR in cervical cancer cell lines and human tumors. Correlations of patients' clinicopathological factors and overall survival with miR-138 expression were analyzed. In SiHa and HeLa cells, miR-138 was either upregulated or downregulated to evaluate its regulations on cervical cancer in vitro proliferation, invasion and in vivo xenograft growth. Downstream target gene of miR-138, TCF3, was analyzed by dual-luciferase reporter assay, and by qRT-PCR to evaluate its expression in cervical tumors and cervical cancer cell lines. TCF3 was either upregulated or downregulated in SiHa and HeLa cells to further evaluate its role in regulating cervical cancer proliferation and invasion. RESULTS: MiR-138 is downregulated in both cervical tumors and cervical cancer cell lines. Low expression of miR-138 in cervical tumors is closely correlated with patients' clinicopathological factors and poor survival. In SiHa and HeLa cells, lentivirus-induced miR-138 upregulation inhibited cancer proliferation and invasion in vitro, and xenograft growth in vivo, whereas miR-138 downregulation had little effect. TCF3 was confirmed to be regulated by miR-138, and upregulated in cervical cancer tumors and cell lines. In vitro cervical cancer proliferation and invasion were significantly inhibited by SiRNA-mediated TCF3 downregulation, but unaffected by TCF3 overexpression. CONCLUSION: MiR-138 may be a tumor suppressor and potential prognostic biomarker in cervical cancer. Its downstream target, TCF3, may also regulate cancer development in a reverse manner as miR-138.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Li H, Sheng Y, Zhang Y, et al. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene. Gynecol Oncol. 2017. PMID: 28385388. doi:10.1016/j.ygyno.2017.01.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。